Back to Journals » OncoTargets and Therapy » Volume 15

Correlations of Microvascular Blood Flow of Contrast-Enhanced Ultrasound and HGF/c-Met Signaling Pathway with Clinicopathological Features and Prognosis of Patients with Hepatocellular Carcinoma [Retraction]

Authors Zhuang PH, Xu L, Gao L, Lu W, Ruan LT, Yang J

Received 21 September 2022

Accepted for publication 21 September 2022

Published 23 September 2022 Volume 2022:15 Pages 1043—1044

DOI https://doi.org/10.2147/OTT.S390682



Zhuang PH, Xu L, Gao L, Lu W, Ruan LT, Yang J. Onco Targets Ther. 2017;10:847–857.

The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. Concerns were raised regarding the alleged duplication of images between Figure 1A, panel HGF, Adjacent normal tissues and Figure 2A, panel HCC tissues. In addition, there also appears to be duplication of images between Figure 4B and C.

The authors did not respond to our queries in regard to the alleged duplication, nor did they provide original data for their study. The Editor requested to retract the article and the authors were notified of this.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


This retraction relates to this paper


Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.